CytoDyn Inc. (CYDY) 近日宣布,公司已获得资金支持,并正式启动针对三阴性乳腺癌患者的扩展性用药项目。这一举措旨在为目前缺乏有效治疗选择的患者群体提供新的治疗可能性。
CytoDyn Inc. (CYDY) 近日宣布,公司已获得资金支持,并正式启动针对三阴性乳腺癌患者的扩展性用药项目。这一举措旨在为目前缺乏有效治疗选择的患者群体提供新的治疗可能性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.